The establishment of EVISA is funded by the EU through
the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
A gadolinium-based paramagnetic contrast agent. When placed in a
magnetic field, gadobenate dimeglumine produces a large magnetic moment
and so a large local magnetic field, which can enhance the relaxation
rate of nearby protons; as a result, the signal intensity of tissue
images observed with magnetic resonance imaging (MRI) may be enhanced.
Because this agent is preferentially taken up by normal functioning
hepatocytes, normal hepatic tissue is enhanced with MRI while tumor
tissue is unenhanced. In addition, because gadobenate dimeglumine is
excreted in the bile, it may be used to visualize the biliary system
The term "gadobenate dimeglumine" was found in the following pages: